-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RFaieG8n6rxp8xRIBe/XDKPHP+nAiIxuXeNzoOh4RY9pmF24vsAeOcHhgTC8mF6a 8Omg2mybT4zINcAlo+WCew== 0000950103-96-000923.txt : 19960612 0000950103-96-000923.hdr.sgml : 19960612 ACCESSION NUMBER: 0000950103-96-000923 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19960603 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 19960607 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: MELVILLE CORP CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 041611460 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 96578254 BUSINESS ADDRESS: STREET 1: ONE THEALL ROAD CITY: RYE STATE: NY ZIP: 10580 BUSINESS PHONE: 9149254000 MAIL ADDRESS: STREET 1: ONE THEALL ROAD CITY: RYE STATE: NY ZIP: 10580 FORMER COMPANY: FORMER CONFORMED NAME: MELVILLE SHOE CORP DATE OF NAME CHANGE: 19760630 8-K 1 ============================================================================== SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 1996 MELVILLE CORPORATION - ------------------------------------------------------------------------------ (Exact Name of Registrant as Specified in its Charter) New York 1-1011 04-1611460 -------------------- ------------------------ -------------------- (State or Other (Commission File Number) (IRS Employer Jurisdiction Identification of Incorporation) No.) One Theall Road Rye, New York 10580 -------------------- -------------------- (Address of Principal (Zip Code) Executive Offices) Registrant's telephone number, including area code: (914) 925-4000 Not Applicable - ------------------------------------------------------------------------------ (Former Name or Former Address, if Changed Since Last Report) ============================================================================== ITEM 5. Other Events. ------------ Melville Corporation issued a press release on June 3, 1996 announcing further actions relating to its strategic restructuring program. The information contained in the press release is incorporated herein by reference. The press release is attached hereto as Exhibit 99.1. ITEM 7(c). Exhibits. -------- Exhibit 99.1 Press Release of Melville Corporation dated June 3, 1996. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MELVILLE CORPORATION /s/ Carlos Alberini Dated: June 7, 1996 By:_______________________ Name: Carlos Alberini Title: Chief Financial Officer INDEX TO EXHIBITS Sequential Exhibit No. Description Page No. - ----------- ----------- ---------- Exhibit 99.1 Press Release of Melville Corporation dated June 3, 1996. EX-99.1 2 Exhibit 99.1 Investor Contact: Nancy Christal Media Contact: Wendi Kopsick Vice President Jim Fingeroth Investor Relations Kekst and Company (914) 925-4385 (212) 593-2655 FOR IMMEDIATE RELEASE --------------------- MELVILLE TAKES STEPS TO ACCELERATE COMPLETION OF RESTRUCTURING AND EXPEDITE CVS AS A STAND-ALONE CHAIN DRUG COMPANY -- Footstar Earnings Expected to Benefit from Thom McAn Closings -- RYE, NEW YORK, June 3, 1996 -- Melville Corporation (NYSE: MES) today announced steps to accelerate the emergence of CVS Corporation as a stand-alone chain drug retailing company and to further strengthen Footstar, Inc., a new company consisting of Melville's footwear businesses that is to be spun off to shareholders. The actions clear the way for final completion of Melville's strategic restructuring program this summer. These actions include: (1) classifying Linens 'n Things and Bob's results as discontinued operations, demonstrating the company's formal plan to separate these divisions from CVS Corporation; (2) a formal plan to convert 80 to 100 of Thom McAn's stores to the highly successful Footaction format and to exit the Thom McAn business by mid-1997. Primarily as a result of these actions, the company will record a one-time, after-tax charge of approximately $148 million in the second quarter of 1996. Melville also reported that it plans to monetize the TJX Companies, Inc. preferred stock it received as part of the sale of its Marshalls division to TJX in November 1995. The monetization of these securities is expected to occur in the third quarter of 1996. Based on the closing price on May 31, 1996 of TJX common stock, into which the preferred stock is convertible, this would result in a pretax gain of approximately $150 million. "These steps will expedite the completion of our restructuring program," said Stanley Goldstein, Chairman and Chief Executive Officer. "With Linens 'n Things and Bob's now classified as discontinued operations, investors will be better able to analyze CVS as a stand-alone chain drug retailer. In addition, exiting the Thom McAn business and the conversion of some of its very desirable real estate to the Footaction format is expected to produce annual earnings improvements for Footstar, Inc. "These actions follow the sales of Wilsons, in late May, and This End Up, announced earlier today, as well as those of Kay-Bee Toys, completed in early May, and Marshalls, completed last November. We are on schedule to complete the spinoff of Footstar in July, and, with the actions announced today, will have substantially completed Melville's restructuring at that time," Mr. Goldstein said. Since October 1995, Melville has been implementing a strategic restructuring program, which was the product of a strategic review initiated in 1994. The main components of the restructuring include the creation of two publicly-traded, independent and industry- focused companies -- CVS Corporation in the chain drug industry and Footstar, Inc. in the footwear industry -- a significant reduction in costs, the sale of Melville's mature or unrelated businesses, and the closing of approximately 330 underperforming stores. # # # -----END PRIVACY-ENHANCED MESSAGE-----